Loading...
Chimeric Antigen Receptor T cells for Multiple Myeloma: The Journey So Far – And the Road Ahead
Despite improvements in effective therapy, multiple myeloma remains incurable and virtually all patients will face relapsed disease at some point after diagnosis. The prognosis for relapsed myeloma after developing resistance to anti-CD38 monoclonal antibodies, proteasome inhibitors, immunomodulator...
Na minha lista:
| Udgivet i: | Cancer J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988823/ https://ncbi.nlm.nih.gov/pubmed/33750070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000506 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|